Published in Bone Marrow Transplant on June 01, 2001
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood (2012) 1.01
Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA). Blood (2009) 0.95
Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere length. PLoS One (2017) 0.75
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science (1998) 11.23
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (1987) 7.88
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. Lancet (2000) 4.55
Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed (2001) 4.38
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet (1992) 3.54
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet (1993) 3.36
How to run an induction meeting for house officers. BMJ (1992) 3.32
Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J Virol (1994) 3.32
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature (1986) 3.19
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int J Radiat Oncol Biol Phys (1993) 3.03
Terminology and classification of the cortical dysplasias. Neurology (2004) 2.99
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Mutagenesis of a shuttle vector plasmid in mammalian cells. Mol Cell Biol (1984) 2.77
Inappropriate antihypertensive therapy in the elderly. Lancet (1976) 2.71
PMWS and porcine dermatitis nephropathy syndrome in Great Britain. Vet Rec (2000) 2.67
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci (1995) 2.62
Synaptotagmin VII regulates Ca(2+)-dependent exocytosis of lysosomes in fibroblasts. J Cell Biol (2000) 2.55
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A (2000) 2.47
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet (1991) 2.39
The isolation of reovirus-like agents (rota-viruses) from acute gastroenteritis of piglets. J Med Microbiol (1976) 2.12
Deletion of the vaccinia virus growth factor gene reduces virus virulence. J Virol (1988) 2.10
Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet (1999) 2.06
Hepatitis G virus in long-term survivors of haematological malignancy. Lancet (1996) 2.05
Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. Int J Clin Pract (2010) 2.03
A patient of Russell's viper envenomation presenting with cortical venous thrombosis: an extremely uncommon presentation. J Postgrad Med (2013) 2.03
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med (1988) 2.02
Intramolecular recombination between transfected repeated sequences in mammalian cells is nonconservative. Mol Cell Biol (1986) 1.99
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. Clin Rehabil (2002) 1.94
Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS (2000) 1.94
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol (1976) 1.92
Psychoeducational intervention for caregivers of Indian patients with schizophrenia: a randomised-controlled trial. Acta Psychiatr Scand (2009) 1.90
Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology (2000) 1.82
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract (2009) 1.79
The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood (1975) 1.77
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet (2001) 1.76
No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics (2001) 1.76
Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant (2003) 1.73
Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology (2003) 1.65
Coronary artery disease and women. BMJ (1994) 1.65
Psychosocial factors associated with relapse in men with alcohol or opioid dependence. Indian J Med Res (2009) 1.64
Postmenopausal HRT--a role for tamoxifen? Int J Clin Pract (1998) 1.64
Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs. Heart (1999) 1.63
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract (2013) 1.61
Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology (1988) 1.60
Strychnine poisoning treated successfully with diazepam. Br Med J (1971) 1.59
Intracardiac spread of intravenous leiomyomatosis with successful surgical excision. N Engl J Med (1980) 1.59
Faking it: the dangers of counterfeit medicine on the internet. Int J Clin Pract (2009) 1.58
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2013) 1.58
Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood (1993) 1.56
The rise of post-traumatic stress disorders. BMJ (1991) 1.56
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J Virol (1990) 1.56
Cell proliferative response to vaccinia virus is mediated by VGF. Virology (1988) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Raised exercise diastolic blood pressure as indicator of ischaemic left ventricular dysfunction. Lancet (1991) 1.51
Postmenopausal hormone replacement therapy in hypertensive women: is it time for a change in attitude? J Hum Hypertens (1998) 1.50
Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res (2000) 1.49
Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology (1998) 1.49
Avoidable mortality in New Zealand, 1981-97. Aust N Z J Public Health (2001) 1.49
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol (1997) 1.48
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol (1991) 1.48
In vitro suppression of transforming growth factor-beta induced stimulation of glycosaminoglycan synthesis by acetylsalicylic acid and its reversal by misoprostol. J Rheumatol (1998) 1.47
Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol (1979) 1.46
Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46
Peripartum cardiomyopathy due to myocarditis. N Engl J Med (1982) 1.46
Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46
Ventricular stroke work loss: validation of a method of quantifying the severity of aortic stenosis and derivation of an orifice formula. J Am Coll Cardiol (1990) 1.45
Interface between primary care and specialist mental health care. Br J Gen Pract (1992) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses. Proc Natl Acad Sci U S A (1989) 1.44
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Early exercise testing and coronary angiography after uncomplicated myocardial infarction. Br Med J (Clin Res Ed) (1982) 1.43
Unexplained breathlessness and psychiatric morbidity in patients with normal and abnormal coronary arteries. Lancet (1983) 1.43
Chelation therapy is TACT-less. Int J Clin Pract (2008) 1.42
JUPITER: wake up and smell the coffee--the absolute and relative merits of statin use. Int J Clin Pract (2009) 1.42
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol (1997) 1.42
Possible linkage of Tourette syndrome to markers on short arm of chromosome 3 (C3p21-14) Lancet (1990) 1.42
Development of polycythaemia rubra vera following treatment for centroblastic lymphoma. Acta Haematol (1996) 1.41
Never mind the content, measure the impact: spin bowling for journal impact factors vs. the importance of patient impact. Int J Clin Pract (2010) 1.40
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
Hazards of routine endotracheal suction in the neonatal unit. Lancet (1989) 1.39
The impact of the principles of evidence interpretation on the structure and content of statements. Sci Justice (2000) 1.39
American journal owners 2, principled editors 0. Int J Clin Pract (2000) 1.39
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood (1989) 1.39